🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main purpose of this study is to determine the dose of poly-ICLC that i...
Status
Completed
Location
Georgia Cancer Center at Augusta University
Start Date
2018-01-10
Trial ID
NCT02834052
Treatments Being Tested
This phase I trial studies the side effects of DEC-205/NY-ESO-1 fusion prot...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2018-03-27
Trial ID
NCT03358719
This phase I trial evaluates the safety and effectiveness of in situ immuno...
Status
Active Not Recruiting
Location
Los Angeles General Medical Center
Start Date
2023-01-09
Trial ID
NCT04616248
This phase I trial studies the safety of personalized neo-antigen peptide v...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2022-06-09
Trial ID
NCT05098210
This phase I trial studies the side effects and how well of pembrolizumab a...
Status
Active Not Recruiting
Location
Quan
Start Date
2020-01-08
Trial ID
NCT04201873
Treatments Being Tested
This phase II trial studies the effect of a vaccine called CDX-1401 given w...
Status
Completed
Location
University of Chicago Comprehensive Cancer Center
Start Date
2014-04-09
Trial ID
NCT02129075
Treatments Being Tested
The purpose of this study is to test an approach of stimulating the body's ...
Status
Completed
Location
Icahn School of Medicine at Mount Sinai
Start Date
2017-06-16
Trial ID
NCT03262103
This early phase I trial evaluates the side effects of BO-112 and pembroliz...
Status
Terminated
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2021-10-13
Trial ID
NCT04777708
Treatments Being Tested
This phase I trial tests the safety and side effects, and best dose of a va...
Status
Active Not Recruiting
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2024-06-14
Trial ID
NCT06342908
Treatments Being Tested
The investigators propose the development of a range of nasal spray challen...
Status
Completed
Location
Imperial Clinical Respiratory Research Unit (ICRRU), St Mary's Hospital
Start Date
2014-03
Trial ID
NCT02090374
Treatments Being Tested